1,768 results on '"Löffler, H."'
Search Results
2. 738P Combined ipilimumab and nivolumab in previously treated patients with cancer of unknown primary: Results of the CheCUP trial
3. 185P Multi-omics profiling and clinical characterization of colon-like cancer of unknown primary (CUP)
4. 1266P Interim analysis from the multicenter ROSE study: Radiation during osimertinib treatment safety and efficacy cohort
5. Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia
6. Biology Oriented Investigation of Treatment Strategies for Acute Myeloid Leukemia (AML): The AMLCG Approach
7. RT-PCR in Diagnostics and Monitoring of Acute Myeloid
8. Although Patients with AML and Complex Aberrant Karyotype Can be Subdivided Into Different Subtypes by Cytogenetics, Prognosis is Equally Poor
9. In vitro selection for heat-tolerance in Lilies
10. The Prognostic Impact of Trisomy 8 in Acute Myeloid Leukemia: Do Accompanying Aberrations Influence Prognosis?
11. Routinely Prepared Cells for Cytogenetic Analysis Stored at −20 °C for Several Years can be Used for RT-PCR-Based Detection of Chromosomal Aberrations in Leukemias
12. Monitoring of PML-RAR alpha in Patients with Acute Promyelocytic Leukemia (APL) by RT-PCR
13. All-Trans Retinoic Acid (ATRA) Combined with Double Induction Strategy in Acute Promyelocytic Leukemia (APL). Preliminary Results
14. Biologic Determinants for AML Therapy
15. Cytomorphology and Clinical Outcome in 80 Patients with AML M4Eo and Inversion 16
16. Detection of Minimal Residual Disease on Bone Marrow Smears by Reverse Transcriptase Polymerase Chain Reaction
17. Adoptive Transfer of NK Cells Can Eradicate Residual Leukemia After BMT
18. Prognostic Value of Dysmyelopoiesis in 128 Patients with De Novo Acute Myeloid Leukemia
19. Fifty-nine Cases of Acute Myeloid Leukemia with Inversion inv(16) (p13q22): Do Additional Chromosomal Aberrations Influence Prognosis?
20. Therapie der B-ALL und lymphoblastischer B-NHL in den multizentrischen ALL-Studien des Erwachsenen
21. Simulation von Kommunikationssystemen
22. Natural Killer Cell Alloreactivity Against Acute Leukemia Blasts: The Level of Activity Depends on the Individual Target-Effector Pair
23. Salvage Therapy of Adult ALL
24. Hematologic and Therapeutic Effects of High-Dose AraC/Mitoxantrone (HAM) in the Induction Treatment of Patients with Newly Diagnosed AML. A Trial by AML Cooperative Group
25. Biological Entities in Acute Myelogenous Leukemia According to Morphological, Cytogenetic and Immunological Criteria: Data of Study AML-BFM-87
26. Acute Myeloid Leukemia with Translocation (8;21). Cytomorphology, Dysplasia and Prognostic Factors in 41 Cases
27. Graft-Versus Leukemia Activity in Experimental Bone Marrow Transplantation: The Impact of Natural Killer Cells and Graft-Versus-Host Disease
28. Graft Rejection After Allogeneic Bone Marrow Transplantation: The Impact of T Cells, Graft-Versus-Host Reaction and Marrow Cell Number
29. Chemotherapy Intensity and Long-Term Outcome in AML
30. Zytochemische Methoden
31. Strukturierte Diagnostik und internistische Therapie des CUP-Syndroms
32. CUP-Syndrom: Epidemiologie und Pathogenese
33. Immunophenotype of Acute Myeloid Leukemia: Correlation with Morphological Characteristics and Therapy Response
34. Morphologic Basis for the MIC Classification in Acute Myeloid Leukemia
35. Chromosomal Abnormalities in Adult Acute Lymphoblastic Leukemia: Results of the German ALL/AUL Study Group
36. Chemotherapy for Adult Acute Myeloid Leukemia: Study Results from the Acute Myeloid Leukemia Cooperative Group and Overview
37. CD48 Monoclonal Antibody K31 for Bone Marrow Transplantation: Functional Characteristics
38. High-Dose Cytosine Arabinoside and Mitoxantrone (HAM) in the Treatment of Acute Leukemias: Results of Salvage and First Line Treatment
39. Two Murine Leukemia Models for the Investigation of New Treatment Strategies in Bone Marrow Transplantation
40. Engraftment-Promoting Potential of High-Dose Cytostatic Agents in Allogeneic Bone Marrow Transplantation
41. Megaloblastische Anämien
42. Intensive Chemotherapy in Myelodysplastic Syndromes
43. Einsatz von EMLA Creme bei Ulcus cruris: Nutzen und Grenzen
44. Zelldifferenzierung
45. Danube Backwaters and Their Response to Anthropogenic Alteration
46. Clinical Importance of T-ALL Subclassification According to Thymic or Prethymic Maturation Stage
47. Acute Megakaryoblastic Leukemia (FAB-M7) in an Infant Presenting with Orbital Chloroma and Meningeal Involvement
48. Acute Megakaryoblastic Leukemia: A Case Report
49. Adult AML: The Role of Chemotherapy Intensity and Duration. Two Studies of the AML Cooperative Group
50. Morphology, Immunology, Cytochemistry, and Cytogenetics and the Classification of Subtypes in AML
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.